ROYAL BANK OF CANADA - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 1 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$4,290,000
-74.2%
24,825
-82.9%
0.00%
-72.7%
Q4 2014$16,657,000
+20.7%
144,928
+64.0%
0.01%
+22.2%
Q3 2014$13,805,000
-17.6%
88,360
-34.9%
0.01%
-18.2%
Q2 2014$16,753,000
+19.4%
135,817
+0.3%
0.01%
+10.0%
Q1 2014$14,027,000
-2.0%
135,391
-14.9%
0.01%0.0%
Q4 2013$14,311,000
+0.8%
159,111
-25.1%
0.01%
-9.1%
Q3 2013$14,203,000
+14.7%
212,365
+13.4%
0.01%
+10.0%
Q2 2013$12,387,000187,2590.01%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 300,000$46,872,00024.29%
HealthCor Management, L.P. 935,100$146,100,0007.50%
1492 Capital Management LLC 70,167$10,963,0006.07%
Visium Asset Management, LP 2,301,629$359,607,0005.31%
HWG Holdings LP 39,621$6,190,0004.97%
Riggs Asset Managment Co. Inc. 45,649$7,132,0004.14%
Cardinal Capital Management 49,139$7,677,0003.65%
AMI ASSET MANAGEMENT CORP 213,398$33,341,0003.27%
BENNETT LAWRENCE MANAGEMENT L L C/NY 88,435$13,817,0003.14%
Adamant Biomedical Investments AG 78,210$12,220,0003.05%
View complete list of SALIX PHARMACEUTICALS INC shareholders